Navigation Links
Beat menopausal symptoms with low-dose estrogen

Results of two new studies suggest that low-dose estrogen therapy should be considered first line treatment for women experiencing menopausal hot flushes and bleeding. The June issue of Fertility and Sterility says low-dose estrogen therapy is as effective as high-dose estrogen in treating menopausal symptoms. Low-doses are actually are more effective in stopping the irregular bleeding.

Dr. Wulf H. Utian, a professor at Case Western Reserve University and president of The North American Menopasue Society in Cleveland, Ohio, headed the research. He noted that side effects such as breast tenderness, irregular bleeding and negative mood, as well as the fear of breast cancer risk, cause many women to discontinue Hormone Replacement Therapy (HRT).//

While HRT can relive some of the painful and debilitating symptoms of menopause, reduce the risk of heart disease and protect aginst endometrial cancer, it may also raise a woman's risk of breast cancer, particularly at higher doses. On the contrary, the advantages of low-dose therapy is that a patient can get the same effect as with higher doses and also reduce the side effects.

A second study of the same group of women found that lower doses of hormones stopped irregular bleeding more effectively than did higher dose HRT over one year, particularly in the earlier stages of therapy.


'"/>




Page: 1

Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with CAD
2. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
3. Exercise The Ideal Solution For Postmenopausal Women
4. Enlarged waistline may predict atherogenesis for postmenopausal women
5. Research explains why postmenopausal women accumulate abdominal fat.
6. Insight for Hot Flashes In Postmenopausal Women
7. New Insight In Periodontal Disease In Postmenopausal Women
8. Low bone mass in Postmenopausal Women
9. Consumption of Soy May Reduce Risk of Fracture in Postmenopausal Women
10. Testosterone Therapy can improve sexual function in postmenopausal women
11. Perimenopausal Hormone Therapy Fights Heart Disease
Post Your Comments:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...ested in blood to indicate the possibility// of he...eport in the 7th July 2005 issue of New England ...s of Oxidized phospholipids may indicate the amoun... their arteries of heart. This test may in future ...
...specially the role of fats, had been debated for a...ersity had found out that the between the various ...ssible to have the healthy meal by banishing one k... kind of fats. The right combination of both can h...
...h is good for the heart. A recent study undertaken...e University of Minnesota Medical School has found...mmation in the body is less and there is also a lo... The substance that helps is omega-3 fatty acids i...
...reduce the risk of contacting HIV from intercourse...study involved 3,000 HIV negative men in Africa be...ther half were not circumcised. They were follow... that for every ten uncircumcised men who became i...
Other Medicine News:
(Date:10/8/2008)... Findings Confirm Potency of Poly-ICR as Va...stCall/ -- Nventa Biopharmaceuticals,Corporation (...inical,studies using its proprietary Toll-like Rec... at the World Vaccine Congress 2008 in Lyon, Franc...ent vaccine adjuvant,targeting the Toll-like Recep...
(Date:10/8/2008)... -- Exploratory study shows clinical improvement ...ion (PAH), -- Current treatment options have li...progressive and incurable blood vessel disease, ... treatment of certain cancers, known to inhib...further explore potential of imatinib mesylate in ...
(Date:10/7/2008)... FLINT, Mich., Oct. 7 /- McLaren Hea...gathering some of the world,s leading medical,mind...be on breast and,gastrointestinal cancer treatment...nd GLCI, was organized by McLaren,s Sukamal Saha, ...ork in sentinel node mapping for,colorectal cancer...
(Date:10/7/2008)... AUSTIN, Texas, Oct. 7 /- The Texas ... Medical Center has been selected as one of,only a...approved clinical,trial for a new device to treat ...onal treatment, training and research center speci...p between St. David,s Medical Center and,Texas Car...
Breaking Medicine Technology:Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Study of successful drug targets could hasten development of new medications 2089 1Study of successful drug targets could hasten development of new medications 2089 2Study of successful drug targets could hasten development of new medications 2089 3Ecological genetics of freshwater bacteria surveyed 2087 1Ecological genetics of freshwater bacteria surveyed 2087 2Prostate cancer 3A Watchful wait or vaccinate 3F 2085 1Prostate cancer 3A Watchful wait or vaccinate 3F 2085 2Prostate cancer 3A Watchful wait or vaccinate 3F 2085 3Scientists discover new species of giant elephant shrew 2083 1Scientists discover new species of giant elephant shrew 2083 2Scientists discover new species of giant elephant shrew 2083 3
...hael S. Singer, M.D., Ph.D. Corresponding Editor H...s of bird flu (avian influenza) reported in Asia a...ved swiftly to develop policies on surveillance, d... the H5N1 subtype of influenza A, which has become...ntries. First in 1997 and now recently, some huma...
...hael S. Singer, M.D., Ph.D. ,Contributing Editor...lethal condition that affects 7% of individuals so...the appendix, a blind pouch of intestine at the pr...or lymphatic tissue. Infection ensues, which can ...k of these complications, already elevated for chi...
Other Medicine Technology:Avian (Bird) Flu: Is There a Role for Rapid Tests? 2Avian (Bird) Flu: Is There a Role for Rapid Tests? 3Appendicitis: Evolving Tools to Diagnose a Classic Disease 2Appendicitis: Evolving Tools to Diagnose a Classic Disease 3
Immuno-turbidimetric Assay of D-Dimer by STA© Analyzers. Microlatex particles coated with two different mouse monoclonal anti-human D-Dimer antibodies.
Latex Agglutination Slide Test for the Qualitative and Semi-Quantitative Determination of D-Dimer in plasma, 60 tests.
Detection of Lupus Anticoagulants. Freeze-dried hexagonal phase phos-phatidylethanolamine; normal plasma with heparin inhibitor; PTT-LS reagent of cephalin and particulate siliceous activator;all fre
Antigenic Total Protein S, ELISA Method
Medicine Products: